The DOI matches its Crossref record; 486 of the 486 references it cites were found in a registry or an index.
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 486
Kenakin, T. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01136-x · Cited by 227
Self-citationCrystal Structure of a Thermally Stable Rhodopsin Mutant
Standfuss, J., Xie, G., Edwards, P. C., Burghammer, M., Oprian, D. D., & Schertler, G. F. X. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.007 · Cited by 225
Ellis, J., Pediani, J. D., Canals, M., Milasta, S., & Milligan, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602494200 · Cited by 225
Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Bonhaus, D. W., Chang, L. K., Kwan, J., & Martin, G. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37876-0 · Cited by 223
Maeda, K., Nakata, H., Koh, Y., Miyakawa, T., Ogata, H., Takaoka, Y., Shibayama, S., Sagawa, K., Fukushima, D., Moravek, J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8654-8662.2004 · Cited by 221
Ernst, O. P., Gramse, V., Kolbe, M., Hofmann, K. P., & Heck, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701967104 · Cited by 218
How and why do GPCRs dimerize?
Gurevich, V. V., & Gurevich, E. V. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.02.004 · Cited by 217
Hilser, V. J., Dowdy, D., Oas, T. G., & Freire, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9903 · Cited by 215
Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
Doranz, B. J., Lu, Z. H., Rucker, J., Zhang, T. Y., Sharron, M., Cen, Y. H., Wang, Z. X., Guo, H. H., Du, J. G., Accavitti, M. A., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6305-6314.1997 · Cited by 214
Kenakin, T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.009 · Cited by 213
Self-citationAldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 212
Label-Free Cell-Based Assays with Optical Biosensors in Drug Discovery
Fang, Y. (2006) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2006.4.583 · Cited by 212
Alkhatib, G., Locati, M., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1997) · Virology · doi:10.1006/viro.1997.8673 · Cited by 210
Ulrich, C. D., Holtmann, M., & Miller, L. J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70491-3 · Cited by 209
Self-citationA Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5
O’Brien, J. A., Lemaire, W., Chen, T.-B., Chang, R. S. L., Jacobson, M. A., Ha, S. N., Lindsley, C. W., Schaffhauser, H. J., Sur, C., Pettibone, D. J., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.731 · Cited by 209
Lombardi, M. S., Kavelaars, A., Schedlowski, M., Bijlsma, J. W. J., Okihara, K. L., van de Pol, M., Ochsmann, S., Pawlak, C., Schmidt, R. E., & Heijnen, C. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.715 · Cited by 208
Gesty-Palmer, D., Flannery, P., Yuan, L., Corsino, L., Spurney, R., Lefkowitz, R. J., & Luttrell, L. M. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000071 · Cited by 205
Tsamis, F., Gavrilov, S., Kajumo, F., Seibert, C., Kuhmann, S., Ketas, T., Trkola, A., Palani, A., Clader, J. W., Tagat, J. R., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5201-5208.2003 · Cited by 203
G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling
Breitwieser, G. E. (2004) · Circulation Research · doi:10.1161/01.res.0000110420.68526.19 · Cited by 201
Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways
Urban, J. D., Vargas, G. A., von Zastrow, M., & Mailman, R. B. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301071 · Cited by 197
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2790-2807.2004 · Cited by 196
Kim, Y.-M., & Benovic, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204528200 · Cited by 195
Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers
El-Asmar, L., Springael, J.-Y., Ballet, S., Andrieu, E. U., Vassart, G., & Parmentier, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003624 · Cited by 195
Zamah, A. M., Delahunty, M., Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202753200 · Cited by 195
Grace, C. R. R., Perrin, M. H., DiGruccio, M. R., Miller, C. L., Rivier, J. E., Vale, W. W., & Riek, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404702101 · Cited by 193
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
Hilairet, S., Bouaboula, M., Carrière, D., Le Fur, G., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 190
Seven-Transmembrane Receptor Signaling Through β-Arrestin
Shenoy, S. K., & Lefkowitz, R. J. (2005) · Science's STKE · doi:10.1126/stke.2005/308/cm10 · Cited by 189
Baker, J. G., Hall, I. P., & Hill, S. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1357 · Cited by 189
A Statistical Thermodynamic Model of the Protein Ensemble
Hilser, V. J., García-Moreno E., B., Oas, T. G., Kapp, G., & Whitten, S. T. (2006) · Chemical Reviews · doi:10.1021/cr040423+ · Cited by 187
McLaughlin, J. N., Shen, L., Holinstat, M., Brooks, J. D., DiBenedetto, E., & Hamm, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414090200 · Cited by 186
Oppermann, M., Mack, M., Proudfoot, A. E. I., & Olbrich, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8875 · Cited by 185
Molecular Recognition by Induced Fit: How Fit is the Concept?
Bosshard, H. R. (2001) · Physiology · doi:10.1152/physiologyonline.2001.16.4.171 · Cited by 184
Hamdan, F. F., Audet, M., Garneau, P., Pelletier, J., & Bouvier, M. (2005) · SLAS Discovery · doi:10.1177/1087057105275344 · Cited by 183 · cited 1×
“…et al., 2005; Ross et al., 2008; Hanson et al., 2009; van der Lee et al., 2009), with bioluminescence resonance energy transfer (Milligan, 2004; Hamdan et al., 2005), with enzyme fragment complementation (Olson and Eglen, 2007; Zhao et al., 2008; van der Lee et al., 2009), or with…”
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato, R., Schulz, S., Waser, B., Eltschinger, V., Rivier, J., Wester, H.-J., Culler, M. D., Ginj, M., Liu, Q., Schönbrunn, A., et al. (2006) · PubMed · Cited by 183
The receptor concept: pharmacology's big idea
Rang, H. P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706457 · Cited by 181
Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists
Kondru, R., Zhang, J., Ji, C., Mirzadegan, T., Rotstein, D., Sankuratri, S., & Dioszegi, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042101 · Cited by 180
G-Protein-Coupled Receptors: From Classical Modes of Modulation to Allosteric Mechanisms
Bridges, T. M., & Lindsley, C. W. (2008) · ACS Chemical Biology · doi:10.1021/cb800116f · Cited by 179
Ligand binding to proteins: The binding landscape model
Miller, D. W., & Dill, K. A. (1997) · Protein Science · doi:10.1002/pro.5560061011 · Cited by 178
Edeling, M. A., Mishra, S. K., Keyel, P. A., Steinhauser, A. L., Collins, B. M., Roth, R., Heuser, J. E., Owen, D. J., & Traub, L. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.01.016 · Cited by 175
Lipid–protein interactions in GPCR-associated signaling
Escribá, P. V., Wedegaertner, P. B., Goñi, F. M., & Vögler, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.001 · Cited by 175
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
Valant, C., Gregory, K. J., Hall, N. E., Scammells, P. J., Lew, M. J., Sexton, P. M., & Christopoulos, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803801200 · Cited by 173
Schwartz, T. W., & Holst, B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.008 · Cited by 173
Willins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
Offermanns, S., Wieland, T., Homann, D., Sandmann, J., Bombien, E., Spicher, K., Schultz, G., & Jakobs, K. H. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10203-4 · Cited by 170
Analysis of Allosterism in Functional Assays
Ehlert, F. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090886 · Cited by 168
Chemokine blockers – therapeutics in the making?
Wells, T. N. C., Power, C. A., Shaw, J. P., & Proudfoot, A. E. I. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.001 · Cited by 167
Receptor Endocytosis Counteracts the Development of Opioid Tolerance
Koch, T., Widera, A., Bartzsch, K., Schulz, S., Brandenburg, L.-O., Wundrack, N., Beyer, A., Grecksch, G., & Höllt, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.004994 · Cited by 167
Albert, P. R., & Robillard, L. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00259-5 · Cited by 167
Kara, E., Crépieux, P., Gauthier, C., Martinat, N., Piketty, V., Guillou, F., & Reiter, E. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0098 · Cited by 166
Kurrasch-Orbaugh, D. M., Watts, V. J., Barker, E. L., & Nichols, D. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042184 · Cited by 166
The Physiology and Pharmacology of Melatonin in Humans
Geoffriau, M., Brun, J., Chazot, G., & Claustrat, B. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023160 · Cited by 164
Allosteric modulation of heterodimeric G-protein-coupled receptors
Milligan, G., & Smith, N. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.001 · Cited by 162
Structural and Molecular Interactions of CCR5 Inhibitors with CCR5
Maeda, K., Das, D., Ogata-Aoki, H., Nakata, H., Miyakawa, T., Tojo, Y., Norman, R., Takaoka, Y., Ding, J., Arnold, G. F., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512688200 · Cited by 162
Cellular assays as portals to seven-transmembrane receptor-based drug discovery
Kenakin, T. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2838 · Cited by 159
Self-citationJi, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 158
Activation-dependent Conformational Changes in β-Arrestin 2
Xiao, K., Shenoy, S. K., Nobles, K., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409785200 · Cited by 158
Functional relevance of neurotransmitter receptor heteromers in the central nervous system
Ferré, S., Ciruela, F., Woods, A. S., Lluís, C., & Franco, R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.001 · Cited by 158
Zheng, H., Loh, H. H., & Law, P.-Y. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039842 · Cited by 158
Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., Leener, A. D., Vassart, G., Doms, R. W., Proudfoot, A. E. J., & Parmentier, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205684200 · Cited by 157
Hogner, A., Kastrup, J. S., Jin, R., Liljefors, T., Mayer, M. L., Egebjerg, J., Larsen, I. K., & Gouaux, E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00650-2 · Cited by 155
GRKs and arrestins: regulators of migration and inflammation
Vroon, A., Heijnen, C. J., & Kavelaars, A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606373 · Cited by 155
β-Arrestin/AP-2 Interaction in G Protein-coupled Receptor Internalization
Laporte, S. A., Miller, W. E., Kim, K.-M., & Caron, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108490200 · Cited by 153
Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1
Pioszak, A. A., Parker, N. R., Suino-Powell, K. M., & Xu, H. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805749200 · Cited by 153
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
Sohy, D., Parmentier, M., & Springael, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705302200 · Cited by 153
Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors
Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D. F., Offord, R. E., Schröder, J.-M., Power, C., & Wells, T. N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32478 · Cited by 153
Receptor activation: what does the rhodopsin structure tell us?
Meng, E. C., & Bourne, H. R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01825-3 · Cited by 152
RAMPs: accessory proteins for seven transmembrane domain receptors
Foord, S. M., & Marshall, F. H. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01347-4 · Cited by 151
Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled Receptors
Wang, Q., Zhao, J., Brady, A. E., et al. (2004) · Science · doi:10.1126/science.1098274 · Cited by 151
Structure and Conformational Changes in the C-terminal Domain of the β2-Adrenoceptor
Granier, S., Kim, S., Shafer, A. M., Ratnala, V. R. P., Fung, J. J., Zare, R. N., & Kobilka, B. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611904200 · Cited by 150
Blanpain, C., Doranz, B. J., Vakili, J., Rucker, J. B., Govaerts, C., Baik, S., Lorthioir, O., Migeotte, I., Libert, F., Baleux, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34719 · Cited by 149
Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights
Johnston, C. A., & Siderovski, D. P. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034348 · Cited by 149
Molecular Characterization of a Purified 5-HT4 Receptor
Banères, J., Mesnier, D., Martin, A., Joubert, L., Dumuis, A., & Bockaert, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412009200 · Cited by 148
Multiple mechanisms of serotonergic signal transduction
Roth, B. L., & Chuang, D. M. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90621-7 · Cited by 148
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions
Mukhopadhyay, S., & Howlett, A. C. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003558 · Cited by 148
Molecular basis of inverse agonism in a G protein–coupled receptor
Vilardaga, J., Steinmeyer, R., Harms, G. S., & Lohse, M. J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio705 · Cited by 147
Molecular Analysis of β2-Adrenoceptor Coupling to Gs-, Gi-, and Gq-Proteins
Wenzel‐Seifert, K., & Seifert, R. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.5.954 · Cited by 147
Asymmetric conformational changes in a GPCR dimer controlled by G‐proteins
Damian, M., Martin, A., Mesnier, D., Pin, J., & Banères, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601449 · Cited by 145
Jones, S. W. (1999) · The Journal of General Physiology · doi:10.1085/jgp.114.2.271 · Cited by 139
Sun, C. C., Song, D., Davis‐Taber, R., Barrett, L. W., Scott, V., Richardson, P. L., Pereda‐Lopez, A., Uchic, M. E., Solomon, L. R., Lake, M. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611397104 · Cited by 138
Demo, A. G., Moss, R. B., Margolick, J. B., Cleghorn, F. R., Sill, A. M., Blattner, W. A., Cocchi, F., Carlo, D. J., DeVico, A. L., & Gallo, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11986 · Cited by 137
Techniques: Promiscuous Gα proteins in basic research and drug discovery
Kostenis, E., Waelbroeck, M., & Milligan, G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.007 · Cited by 136
Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration
Rives, M., Vol, C., Fukazawa, Y., Tinel, N., Trinquet, E., Ayoub, M. A., Shigemoto, R., Pin, J., & Prézeau, L. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.177 · Cited by 133
Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors
Shoemaker, J. L., Ruckle, M. B., Mayeux, P. R., & Prather, P. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089474 · Cited by 133
A new allosteric site in glycogen phosphorylase b as a target for drug interactions
Oikonomakos, N. G., Skamnaki, V. T., Tsitsanou, K. E., Gavalas, N. G., & Johnson, L. N. (2000) · Structure · doi:10.1016/s0969-2126(00)00144-1 · Cited by 132
Grace, C. R., Perrin, M. H., Gulyás, J., DiGruccio, M. R., Cantle, J. P., Rivier, J., Vale, W., & Riek, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700682104 · Cited by 132
Palanché, T., Ilien, B., Zoffmann, S., Reck, M.-P., Bucher, B., Edelstein, S. J., & Galzi, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104363200 · Cited by 132
Park, P. S.-H., Lodowski, D. T., & Palczewski, K. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094630 · Cited by 131
G-protein-independent signaling by G-protein-coupled receptors
Heuss, C., & Gerber, U. R. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01643-x · Cited by 131
Bone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2
Ferrari, S., Pierroz, D. D., Glatt, V., Goddard, D. S., Bianchi, E. N., Lin, F., Manen, D., & Bouxsein, M. (2005) · Endocrinology · doi:10.1210/en.2004-1282 · Cited by 131
Jørgensen, R., Kubale, V., Vrecl, M., Schwartz, T. W., & Elling, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120006 · Cited by 130
‘7TM Receptor Allostery: Putting Numbers to Shapeshifting Proteins
Kenakin, T. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.007 · Cited by 129
Self-citationGurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129
Ullum, H., Cozzi‐Lepri, A., Victor, J., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514192 · Cited by 128
Maelicke, A., Schrattenholz, A. S., Samochocki, M., Radina, M., & Albuquerque, E. X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00214-x · Cited by 126
Interaction of small molecule inhibitors of HIV-1 entry with CCR5
Seibert, C., Ying, W., Gavrilov, S., Tsamis, F., Kuhmann, S. E., Palani, A., Tagat, J. R., Clader, J. W., McCombie, S. W., Baroudy, B. M., et al. (2006) · Virology · doi:10.1016/j.virol.2006.01.018 · Cited by 125
Arrestins Block G Protein-coupled Receptor-mediated Apoptosis
Revankar, C. M., Vines, C. M., Cimino, D. F., & Prossnitz, E. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402121200 · Cited by 124
Katritch, V., Reynolds, K. A., Cherezov, V., Hanson, M. A., Roth, C., Yeager, M. J., & Abagyan, R. A. (2009) · Journal of Molecular Recognition · doi:10.1002/jmr.949 · Cited by 124
Picard, L., Simmons, G., Power, C., Meyer, A., Weiss, R. A., & Clapham, P. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5003-5011.1997 · Cited by 123
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
β-Arrestin 2-Dependent Angiotensin II Type 1A Receptor-Mediated Pathway of Chemotaxis
Hunton, D. L., Barnes, W. G., Kim, J., Ren, X.-R., Violin, J. D., Reiter, É., Milligan, G., Patel, D. D., & Lefkowitz, R. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006270 · Cited by 123
Crystal structure of rhodopsin: implications for vision and beyond
Okada, T. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00227-x · Cited by 121
Chuang, T. T., Sallese, M., Ambrosini, G., Parruti, G., & Blasi, A. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50511-7 · Cited by 121
Lazareno, S., Gharagozloo, P., Kuonen, D. R., Popham, A., & Birdsall, N. J. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.573 · Cited by 121
Peters, M. F., & Scott, C. W. (2009) · SLAS DISCOVERY · doi:10.1177/1087057108330115 · Cited by 121
Milligan, G. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.11.010 · Cited by 121
Kenakin, T., & Morgan, P. H. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10934-6 · Cited by 119
Self-citationLombardi, M. S., Kavelaars, A., Cobelens, P. M., Schmidt, R. E., Schedlowski, M., & Heijnen, C. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1635 · Cited by 118
Identification of Allosteric Peptide Agonists of CXCR4
Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117
Milligan, G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707490 · Cited by 116
Xiao, R.-P., Zhang, S.-J., Chakir, K., Avdonin, P. V., Zhu, W., Bond, R. A., Balke, C. W., Lakatta, E. G., & Cheng, H. (2003) · Circulation · doi:10.1161/01.cir.0000087595.17277.73 · Cited by 116
Evidence for a Negative-Feedback Mechanism in the Biosynthesis of Isoleucine
Umbarger, H. E. (1956) · Science · doi:10.1126/science.123.3202.848.a · Cited by 116
Kinetics of G‐protein‐coupled receptor signals in intact cells
Lohse, M. J., Hein, P., Hoffmann, C., Nikolaev, V. O., Vilardaga, J., & Bünemann, M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707656 · Cited by 115
Receptor activity‐independent recruitment of βarrestin2 reveals specific signalling modes
Terrillon, S., & Bouvier, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600387 · Cited by 115
Blanpain, C., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Migeotte, I., Sharron, M. P., Dupriez, V., Vassart, G., Doms, R. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18902 · Cited by 114
Cussac, D., Boutet-Robinet, E. A., Ailhaud, M., Newman‐Tancredi, A., Martel, J., Danty, N., & Rauly‐Lestienne, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.040 · Cited by 113
Luttrell, L. M. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:253 · Cited by 113
Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Soltys, S., & Koch, W. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811706106 · Cited by 113
Differential Activation and Trafficking of μ-Opioid Receptors in Brain Slices
Arttamangkul, S., Quillinan, N., Low, M. J., von Zastrow, M., Pintar, J. E., & Williams, J. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048512 · Cited by 112
Oakley, R. H., Hudson, C. C., Cruickshank, R. D., Meyers, D. M., Payne, R. E., Rhem, S. M., & Loomis, C. R. (2002) · Assay and Drug Development Technologies · doi:10.1089/154065802761001275 · Cited by 112
Bhattacharya, S., Hall, S. E., Li, H., & Vaidehi, N. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.117648 · Cited by 111
Kim, J., Ahn, S., Rajagopal, K., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808176200 · Cited by 111
Conformational changes: How small is big enough?
Koshland, D. E. (1998) · Nature Medicine · doi:10.1038/2605 · Cited by 110
Seifert, R., Gether, U., Wenzel‐Seifert, K., & Kobilka, B. K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.348 · Cited by 110
Whence cometh the allosterome?
Lindsley, J. E., & Rutter, J. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604452103 · Cited by 109
Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
Jakubík, J., Bačáková, L., Lisá, V., El‐Fakahany, E. E., & Tucek, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8705 · Cited by 109
Daigle, T. L., Kwok, M., & Mackie, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05336.x · Cited by 109
Vroon, A., Kavelaars, A., Limmroth, V., Lombardi, M. S., Goebel, M. U., van Dam, A., Caron, M. G., Schedlowski, M., & Heijnen, C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4400 · Cited by 108
Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108
Whistler, J. L., & von Zastrow, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24575 · Cited by 107
Prather, P. L., Martin, N. A., Breivogel, C. S., & Childers, S. R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26511-1 · Cited by 105
Harikumar, K. G., Pinon, D. I., & Miller, L. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702325200 · Cited by 105
Self-citationZürn, A., Zabel, U., Vilardaga, J., Schindelin, H., Lohse, M. J., & Hoffmann, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052399 · Cited by 105
Takasu, H., Gardella, T. J., Luck, M. D., Potts, J. T. J., & Bringhurst, F. R. (1999) · Biochemistry · doi:10.1021/bi990437n · Cited by 104
Nikolaev, V. O., Hoffmann, C., Bünemann, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603266200 · Cited by 103
Physiological and pharmacological implications of beta-arrestin regulation
Schmid, C. L., & Bohn, L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.005 · Cited by 103
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Self-citationPhosphorylation and regulation of a G protein–coupled receptor by protein kinase CK2
Torrecilla, I., Spragg, E. J., Poulin, B., McWilliams, P., Mistry, S. C., Blaukat, A., & Tobin, A. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610018 · Cited by 103
Zhang, Y., Rodriguez, A. L., & Conn, P. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090308 · Cited by 102
Jarpe, M. B., Knall, C., Mitchell, F. M., Buhl, A. M., Duzic, E., & Johnson, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3097 · Cited by 101
When 7 transmembrane receptors are not G protein-coupled receptors
Rajagopal, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26950 · Cited by 101
Paila, Y. D., & Chattopadhyay, A. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9218-5 · Cited by 100
Mathiesen, J. M., Ulven, T., Martini, L., Gerlach, L. O., Heinemann, Á., & Kostenis, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010520 · Cited by 100
Anborgh, P. H., Seachrist, J. L., Dale, L. B., & Ferguson, S. S. G. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0565 · Cited by 100
Is the slow-exchange core the protein folding core?
Woodward, C. K. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90086-3 · Cited by 98
Bisello, A., Chorev, M., Rosenblatt, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202544200 · Cited by 98
Localization of the Sites Mediating Desensitization of the β2-Adrenergic Receptor by the GRK Pathway
Seibold, A. M., Williams, B., Huang, Z.-F., Friedman, J., Moore, R. H., Knoll, B. J., & Clark, R. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.5.1162 · Cited by 98
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors
Richman, J. G., Kanemitsu-Parks, M., Gaidarov, I., Cameron, J. S., Griffin, P. S., Zheng, H., Guerra, N. C., Cham, L., Maciejewski-Lenoir, D., Behan, D. P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701866200 · Cited by 97
Armour, S. L., Foord, S., Kenakin, T., & Chen, W.-J. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00074-5 · Cited by 96
Self-citationNew approach to drug therapy in Alzheimer's dementia Alfred Maelicke and Edson X. Albuquerque
Maelicke, A., & Albuquerque, E. X. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89089-1 · Cited by 94
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Chidiac, P., Nouet, S., & Bouvier, M. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09338-1 · Cited by 93
Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin Analogs
Liu, Q., Cescato, R., Dewi, D. A., Rivier, J., Reubi, J.-C., & Schönbrunn, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011767 · Cited by 93
Münch, G. W., Dees, C., Hekman, M., & Palm, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16023.x · Cited by 92
Crozier, P., Stevens, M. J., Forrest, L. R., & Woolf, T. B. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.045 · Cited by 92
Orthosteric/Allosteric Bitopic Ligands: Going Hybrid at GPCRs
Valant, C., Sexton, P. M., & Christopoulos, A. (2009) · Molecular Interventions · doi:10.1124/mi.9.3.6 · Cited by 91
Galandrin, S., Oligny-Longpré, G., Bonin, H., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043893 · Cited by 91
Gnagey, A. L., Seidenberg, M., & Ellis, J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1245 · Cited by 91
Conformational changes and drug action.
Burgen, A. S. (1981) · PubMed · Cited by 90
Werry, T. D., Gregory, K. J., Sexton, P. M., & Christopoulos, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03161.x · Cited by 89
When a G protein-coupled receptor does not couple to a G protein
Sun, Y., McGarrigle, D. K., & Huang, X.-Y. (2007) · Molecular BioSystems · doi:10.1039/b706343a · Cited by 89
Peleg, G., Ghanouni, P., Kobilka, B. K., & Zare, R. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151239698 · Cited by 88
Tateyama, M., & Kubo, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505925103 · Cited by 88
Intracellular trafficking of hormone receptors
Gáborik, Z., & Hunyady, L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.06.009 · Cited by 88
Massot, O., Rousselle, J. C., Fillion, M. P., Grimaldi, B., Cloëz-Tayarani, I., Fugelli, A., Prudhomme, N., Seguin, L., Rousseau, B., Plantefol, M., et al. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09375-7 · Cited by 88
Philip, F., Sengupta, P., & Scarlata, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701558200 · Cited by 87
Bailey, C. P., Couch, D., Johnson, E., Griffiths, K., Kelly, E., & Henderson, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10515.2003 · Cited by 87
Gay, E. A., Urban, J. D., Nichols, D. E., Oxford, G. S., & Mailman, R. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.97 · Cited by 87
An Allosteric Circuit in Caspase-1
Datta, D., Scheer, J. M., Romanowski, M. J., & Wells, J. A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.040 · Cited by 85
Hilser, V. J., & Freire, E. (1997) · Proteins Structure Function and Bioinformatics · Cited by 85
Verdonk, E. D., Johnson, K., MCGUINNESS, R. P., Leung, G. K. C., Chen, Y., Tang, H. R., Michelotti, J. M., & Liu, V. F. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.609 · Cited by 84
Amylin receptors: molecular composition and pharmacology
Hay, D. L., Christopoulos, G., Christopoulos, A., & Sexton, P. M. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320865 · Cited by 84
Durroux, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.006 · Cited by 83
Impedance-based cellular assay technologies: recent advances, future promise
McGuinness, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.004 · Cited by 83
Kilts, J. D., Connery, H. S., Arrington, E. G., Lewis, M. M., Lawler, C. P., Oxford, G. S., O’Malley, K. L., Todd, R. D., Blake, B. L., Nichols, D. E., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1179 · Cited by 83
Zhao, X., Jones, A. D., Olson, K. R., Peng, K., Wehrman, T. S., Park, A., Mallari, R., Nebalasca, D., Young, S. W., & Xiao, S.-H. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108321531 · Cited by 83
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor
Quiniou, C., Sapieha, P. S., Lahaie, I., Hou, X., Brault, S., Beauchamp, M., Leduc, M., Řihakova, L., Joyal, J., Nadeau, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6977 · Cited by 82
G Protein-Coupled Time Travel: Evolutionary Aspects of GPCR Research
Römpler, H., Stäubert, C., Thor, D., Schulz, A., Hofreiter, M., & Schöneberg, T. (2007) · Molecular Interventions · doi:10.1124/mi.7.1.5 · Cited by 82
Violin, J. D., DeWire, S. M., Barnes, W. G., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607956200 · Cited by 81
β Galactosidase Complementation: A Cell-Based Luminescent Assay Platform for Drug Discovery
Olson, K. R., & Eglen, R. M. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.052 · Cited by 80
Woo, A. Y., Wang, T.-B., Zeng, X., Zhu, W., Abernethy, D. R., Wainer, I. W., & Xiao, R.-P. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051078 · Cited by 80
Peters, M. F., Knappenberger, K. S., Wilkins, D. E., Sygowski, L. A., Lazor, L. A., Liu, J., & Scott, C. W. (2007) · SLAS DISCOVERY · doi:10.1177/1087057106298637 · Cited by 79
G-protein coupling of μ-opioid receptors (OP3): elevated basal signalling activity
Burford, N. T., Wang, D., & Sadée, W. (2000) · Biochemical Journal · doi:10.1042/bj3480531 · Cited by 78
Sato, M., Horinouchi, T., Hutchinson, D. S., Evans, B. A., & Summers, R. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035337 · Cited by 78
Muniz-Medina, V. M., Jones, S. A., Maglich, J. M., Galardi, C. M., Hollingsworth, R. E., Kazmierski, W. M., Ferris, R. G., EDELSTEIN, M. P., Chiswell, K., & Kenakin, T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052555 · Cited by 78
Self-citationCasadó, V., Cortés, A., Ciruela, F., Mallol, J., Ferré, S., Lluís, C., Canela, E. I., & Franco, R. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.05.010 · Cited by 77
Donnelly, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00546-2 · Cited by 77
A flexible approach for understanding protein stability
Livesay, D. R., Dallakyan, S., Wood, G. G., & Jacobs, D. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.057 · Cited by 76
Gavarini, S., Bécamel, C., Altier, C., Lory, P., Poncet, J., Wijnholds, J., Bockaert, J., & Marin, P. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-03-0218 · Cited by 75
Mak, J., Hisada, T., Salmon, M., Barnes, P. J., & Chung, K. F. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704545 · Cited by 74
Optical biosensor provides insights for bradykinin B2receptor signaling in A431 cells
Ye, F., Li, G., & Peng, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.10.019 · Cited by 74
Hall, D. A., Beresford, I. J. M., Browning, C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702329 · Cited by 74
Herkinorin Analogues with Differential β-Arrestin-2 Interactions
Tidgewell, K. J., Groer, C. E., Harding, W. W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701162g · Cited by 73
G‐protein‐coupled receptor heteromers: function and ligand pharmacology
Franco, R., Casadó, V., Cortés, A., Mallol, J., Ciruela, F., Ferré, S., Lluı́s, C., & Canela, E. I. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707571 · Cited by 71
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid
Pike, N. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27160 · Cited by 71
GPCR Drug Discovery Through the Exploitation of Allosteric Drug Binding Sites
Rees, S., Morrow, D. M., & Kenakin, T. (2002) · Receptors and Channels · doi:10.3109/10606820214640 · Cited by 71
Self-citationAllosteric Modulators: The New Generation of Receptor Antagonist
Kenakin, T. P. (2004) · Molecular Interventions · doi:10.1124/mi.4.4.6 · Cited by 70
Self-citationIkezu, T., Okamoto, T., Ogata, E., & Nishimoto, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81359-t · Cited by 69
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Allostery in Disease and in Drug Discovery
Nussinov, R., & Tsai, C.-J. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 761
Metadata
- Authors
- Kenakin, T., & Miller, L. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 62
- Issue
- 2
- Pages
- 265-304
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2132746917
- Cited by
- 573
- References
- 486
- FWCI
- 27.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.